Drug recall · September 21, 2022
Lisinopril Tablets USP recall
Why: Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03
- Lots / codes
Lot # Q201182, exp. date March 2024
- Quantity
- 11,802 1000-count bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Product was distributed to major distributors/wholesalers nationwide.
- Initiated
- September 13, 2022 · Voluntary: Firm initiated
- Classified
- September 15, 2022
- Reported
- September 21, 2022
- Ended
- January 31, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisinopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.